Bernhardt G. Zeiher
Independent DirectorDr. Bernhardt G. Zeiher, M.D. F.C.C.P. F.A.C.P., also known as Bernie, serves as Independent Director of Entrada Therapeutics, Inc. since April 04, 2023 and serves as its Industry Leader. He serves as Independent Director of Abeona Therapeutics LLC and Abeona Therapeutics Inc. since August 08, 2024. He is Independent Director of Amylyx Pharmaceuticals, Inc. since March 2024. He serves as Member of Scientific Advisory Board of MMS Holdings Inc. since March 2023. He served as Astellas Chief Medical Officer and Interim Head of Gene Therapy, Medical and Development at Audentes Therapeutics, Inc. since 2022 until June 2022. Dr. Zeiher has been Chief Medical Officer of Astellas Pharma, Inc. since April 1, 2018 and serves as President of Development since 2015. Dr. Zeiher serves as President of Development at Astellas Pharma US, Inc. Dr. Zeiher serves as an Executive Vice President and Therapeutic Area Leader of Inflammation, Immunology and Infectious Diseases of Astellas Pharma Global Development, Inc. Dr. Zeiher served as Executive Vice President of Global Development at Astellas Pharma, Inc. He has held a range of board appointments since 2014, including positions at TransCelerate Biopharma, Biotechnology Innovation Organization and Astellas Global Health Foundation. He started his career at Astellas in 2010 as vice president and Therapeutic Area leader for Inflammation, Immunology and Infectious Diseases. He was promoted to senior vice president and Therapeutic Area Head for Immunology, Infectious Diseases and Transplant in 2012. Prior to joining Astellas, he served as the vice president of the Inflammation/Immunology therapeutic area at Pfizer. He served as Medical Director for Inflammation and Immunology at Eli Lilly. Dr. Zeiher received a B.S. in Biology from the University of Toledo, earned his Doctor of Medicine at the Case Western Reserve University School of Medicine and completed an internal medicine residency at University Hospitals of Cleveland as well as a fellowship in Pulmonary and Critical Care Medicine at University of Iowa Hospitals and Clinics. He is also a Fellow in the American College of Physicians and the American College of Chest Physicians.
Positions
- Company NameEntrada Therapeutics, Inc.Stock CodeTRDAPositionIndependent DirectorColleagues
- DDDipal DoshiCEO & Director
- KMKush M. ParmarIndependent Chairman of the Board
- NJNathan J. DowdenPresident & COO
- NSNatarajan SethuramanPresident of Research & Development
- KJKory James WentworthCFO & Treasurer
- JCJared CohenGeneral Counsel
- MTMary T. ThistleIndustry Leader & Independent Director
- PSPeter S. KimDirector
